OXAZOLAM

- Everything we could find out about it

Home ] [ Controlled Substances ] [ Depressants ]

Created Nov 2020

OXAZOLAM

  • [SERENAL]
  • [CONVERTAL]
  • [HIALIZAN]
  • [TRANQUIT]

DEA CODE 2839: Schedule 4

Oxazolam is a long-acting benzodiazepine with general properties similar to those of diazepam. It has been given by mouth for the short-term treatment of anxiety disorders. Oxazolam has also been used as a premedicant in general anaesthesia.

Oxazolam is a prodrug (precursor) for the benzodiazepine desmethyl-diazepam (nordazepam) and is itself a metabolic product of other benzodiazepines. It has anxiolytic, sedative, and anticonvulsant properties. It is a GABA-A receptor agonist. Oxazolam is marketed in Japan under the brand name Serenal. It is usually used to treat anxiety, tension, depression, and sleeping disorder in neurosis. It is used to treat somatic symptoms in psychosomatic disorders (gastrointestinal diseases, circulatory diseases, endocrine diseases, and autonomic dystonia), anxiety, tension, and depression. It is also used as a preanesthetic medication.

Oxazolam
Duration:
RouteOnsetDurationAfter Effects
Tripsit Factsheets
All ROAs:30-90 minutes6-12 hours6-12 hours
Oxazolam Duration

Anxiolytic, anticonvulsant, sedative, and skeletal muscle relaxant properties.

  
Psychomotor Effects of Mexazolam vs. Placebo in Healthy Volunteers - Objective: Mexazolam is an oxazolo-benzodiazepine demonstrating chemical similarities to oxazolam and cloxazolam. This trial aimed to assess the effect of mexazolam on psychomotor performance.
Monday January 10, 2022 - medscape.com

  
Depressants | Link to this page

Home ] [ Controlled Substances ] [ Sources ]


· Controlled Substances
· Depressants
· Oxazolam